Skip to content
QuidelOrtho Corp (QDEL) Stock Price, Key Stats & Insider Trading
Home / Companies / QDEL QDE
QuidelOrtho Corp (QDEL) XNAS IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Net insider buying (90d) Watch QDEL
Latest QDEL Insider Trades
About QuidelOrtho Corp (QDEL) QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Headquarters SAN DIEGO, CA
Employees 6,500
Listed 1981
Exchange XNAS https://www.quidelortho.com SEC filings for QDEL on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Grant or award 40 617,215 Option exercise 22 86,340 Tax withholding / forfeiture 2 2,258
QDEL Insider Transactions (Form 4) 69 85 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 3 of 3.
Date Insider Transaction Security Shares Price Value Sep 15, 2025 RB Ronald Lee Bowman - Officer Grant or award Common Stock 2,565
Recent QDEL Form 8-K Filings 5
QDEL Insider Trading - FAQ
What is the latest insider trade for QDEL? QuidelOrtho Corp (QDEL) had 26 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for QDEL runs to 85 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying QDEL stock? No insider purchases of QDEL were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling QDEL stock? No insider sales of QDEL were filed in the last 90 days. 2 sales are on record for this company.
Where can I see QDEL SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks QDEL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow QDEL insider buys? Create a free InsiderAlpha account and press Watch on this page to add QDEL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track QDEL insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free - Officer
Market cap $1.01B
P/E ratio -
Dividend yield -
Average volume 1.59M
52 week high $35.58
52 week low $9.92
Today's high $15.11
Today's low $14.62
Open $15.09
Volume 1.21M
Previous close $15.32
Shares outstanding 68.58M Market cap
$1.01B
6,500 employees
Most-Active QDEL Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Sep 15, 2025 RB Ronald Lee Bowman - Officer Tax withholding / forfeiture Common Stock 918 $28.92 $27K
Sep 15, 2025 RB Ronald Lee Bowman - Officer Option exercise Restricted Stock Units 2,565 $0.00 -
Jul 15, 2025 KB Kenneth F. Buechler - Director Option exercise Non-Qualified Stock Options 9,215 $0.00 -
Jun 30, 2025 PM Philip D. McLellan - Officer Tax withholding / forfeiture Common Stock 1,951 $28.82 $56K
Jun 30, 2025 PM Philip D. McLellan - Officer Option exercise Restricted Stock Units 4,749 $0.00 -
Jun 30, 2025 JB Joseph M. Busky - Officer Grant or award Common Stock 21,367 $0.00 -
Jun 30, 2025 JB Joseph M. Busky - Officer Tax withholding / forfeiture Common Stock 9,883 $28.82 $285K
Jun 30, 2025 JB Joseph M. Busky - Officer Option exercise Restricted Stock Units 21,367 $0.00 -
Jun 30, 2025 MH Michelle A. Hodges - Officer Tax withholding / forfeiture Common Stock 6,030 $28.82 $174K
Jun 30, 2025 MH Michelle A. Hodges - Officer Option exercise Restricted Stock Units 11,873 $0.00 -
May 29, 2025 KW Kenneth J. Widder - Director Grant or award Restricted Stock Units (Equity Grant) 6,829 $0.00 -
May 29, 2025 KW Kenneth J. Widder - Director Grant or award Restricted Stock Units (Converted) 2,926 $0.00 -
May 29, 2025 KW Kenneth J. Widder - Director Grant or award Restricted Stock Units (Premium) 878 $0.00 -
May 29, 2025 MP Mary Lake Ph D. Polan - Director Grant or award Restricted Stock Units (Equity Grant) 6,829 $0.00 -
May 29, 2025 MP Mary Lake Ph D. Polan - Director Grant or award Restricted Stock Units (Converted) 2,439 $0.00 -
May 29, 2025 KB Kenneth F. Buechler - Director Grant or award Restricted Stock Units (Equity Grant) 6,829 $0.00 -
May 29, 2025 KB Kenneth F. Buechler - Director Grant or award Restricted Stock Units (Converted) 5,365 $0.00 -
May 29, 2025 KB Kenneth F. Buechler - Director Grant or award Restricted Stock Units (Premium) 1,609 $0.00 -
May 29, 2025 AR Ann D. Rhoads - Director Grant or award Restricted Stock Units (Equity Grant) 6,829 $0.00 -
May 29, 2025 AR Ann D. Rhoads - Director Grant or award Restricted Stock Units (Converted) 1,626 $0.00 -
May 29, 2025 AR Ann D. Rhoads - Director Grant or award Restricted Stock Units (Premium) 325 $0.00 -
May 24, 2025 AR Ann D. Rhoads - Director Grant or award Common Stock 546 $0.00 -
May 24, 2025 AR Ann D. Rhoads - Director Grant or award Common Stock 109 $0.00 -
May 24, 2025 AR Ann D. Rhoads - Director Option exercise Restricted Stock Units (Converted) 546 $0.00 -
May 24, 2025 AR Ann D. Rhoads - Director Option exercise Restricted Stock Units (Premium) 109 $0.00 -
May 22, 2025 MP Mary Lake Ph D. Polan - Director Option exercise Restricted Stock Units (Equity Grant) 4,929 $0.00 -
May 22, 2025 AR Ann D. Rhoads - Director Grant or award Common Stock 4,929 $0.00 -
May 22, 2025 AR Ann D. Rhoads - Director Option exercise Restricted Stock Units (Equity Grant) 4,929 $0.00 -
May 22, 2025 KB Kenneth F. Buechler - Director Option exercise Restricted Stock Units (Equity Grant) 4,929 $0.00 -
May 22, 2025 KW Kenneth J. Widder - Director Option exercise Restricted Stock Units (Equity Grant) 4,929 $0.00 -
May 18, 2025 AR Ann D. Rhoads - Director Grant or award Common Stock 427 $0.00 -
May 18, 2025 AR Ann D. Rhoads - Director Grant or award Common Stock 128 $0.00 -
May 18, 2025 AR Ann D. Rhoads - Director Option exercise Restricted Stock Units (Converted) 427 $0.00 -
May 18, 2025 AR Ann D. Rhoads - Director Option exercise Restricted Stock Units (Premium ) 128 $0.00 -
May 18, 2025 KW Kenneth J. Widder - Director Option exercise Restricted Stock Units (Converted) 512 $0.00 -
May 18, 2025 KW Kenneth J. Widder - Director Option exercise Restricted Stock Units (Premium ) 153 $0.00 -
May 18, 2025 KB Kenneth F. Buechler - Director Option exercise Restricted Stock Units (Converted) 789 $0.00 -
May 18, 2025 KB Kenneth F. Buechler - Director Option exercise Restricted Stock Units (Premium ) 236 $0.00 -
Dec 11, 2024 BB Brian J. Blaser - Officer Open-market purchase Common Stock 6,033 $41.42 $250K
Dec 1, 2024 MH Michelle A. Hodges - Officer Tax withholding / forfeiture Common Stock 85 $41.00 $3K
Nov 21, 2024 Carlyle Group Inc. - 10% Owner Open-market sale Common Stock 8,260,183 $35.31 $291.70M
Nov 18, 2024 MH Michelle A. Hodges - Officer Grant or award Restricted Stock Units 16,047 $0.00 -
Nov 8, 2024 MH Michelle A. Hodges - Officer Tax withholding / forfeiture Common Stock 1,417 $43.75 $62K
Oct 15, 2024 MH Michelle A. Hodges - Officer Tax withholding / forfeiture Commom Stock 140 $40.20 $6K
CDI